Among these 5 cases, we detected tumor-specific FGFR2 translocations in > 50% of tumor cells in 4 cases and in 5% of tumor cells in the tumor harboring the FGFR2-UBP1 fusion (Fig 2B). This evidence concerns the gene UBP1 and neoplasm.